tradingkey.logo
tradingkey.logo
Search

Calidi Biotherapeutics Inc

CLDI
Add to Watchlist
1.640USD
+0.177+11.87%
Close 07-31 16:00ETQuotes delayed by 15 min
11.33MMarket Cap
LossP/E TTM

CLDI Financials

See Calidi Biotherapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Calidi Biotherapeutics Inc Earnings Date

Latest Release
May 14, 2026
EPS / Forecast
-0.43/--
Revenue / Forecast
--/--
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-5.95
83.34%
Analyst Rating
STRONG BUY
2025/12/09
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
Financial Indicators
EPS
80.60%-0.43
82.29%-0.57
71.55%-2.21
88.14%-1.99
90.94%-2.21
82.57%-3.22
-45.06%-7.75
49.24%-16.75
-42.94%-24.39
9.93%-18.44
---5.34
---33.00
---17.06
---20.48
----
----
----
----
Revenue
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
-100.00%0.00
-100.00%0.00
--0.00
--0.00
--45.00K
--405.00K
Net Profit
11.41%-4.42M
1.00%-4.06M
-114.13%-10.82M
23.16%-5.71M
30.99%-4.99M
50.21%-4.10M
-149.70%-5.05M
40.50%-7.44M
-11.81%-7.22M
-6.10%-8.23M
62.20%-2.02M
-173.19%-12.50M
16.51%-6.46M
-122.30%-7.76M
---5.36M
---4.58M
---7.74M
---3.49M
Debt to assets ratio
-26.68%9.39%
-64.58%9.96%
-89.06%9.37%
-77.14%18.33%
-87.96%12.81%
-10.98%28.11%
191.54%85.59%
-14.49%80.17%
5.53%106.44%
-85.46%31.58%
--29.36%
--93.76%
--100.86%
--217.14%
----
----
----
----
Revenue
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
-100.00%0.00
-100.00%0.00
--0.00
--0.00
--45.00K
--405.00K
Operating profit
17.29%-4.19M
-10.93%-4.47M
3.41%-5.05M
1.87%-5.66M
25.03%-5.06M
59.00%-4.03M
27.63%-5.23M
11.70%-5.77M
-24.71%-6.75M
-109.47%-9.82M
-3.36%-7.22M
-49.18%-6.54M
23.44%-5.41M
-65.30%-4.69M
---6.99M
---4.38M
---7.07M
---2.84M
Net Profit
11.41%-4.42M
1.00%-4.06M
-114.13%-10.82M
23.16%-5.71M
30.99%-4.99M
50.21%-4.10M
-149.70%-5.05M
40.50%-7.44M
-11.81%-7.22M
-6.10%-8.23M
62.20%-2.02M
-173.19%-12.50M
16.51%-6.46M
-122.30%-7.76M
---5.36M
---4.58M
---7.74M
---3.49M
Current assets
-36.00%7.35M
-38.83%6.26M
396.53%11.03M
272.25%6.05M
493.44%11.49M
137.67%10.23M
-81.00%2.22M
-42.13%1.63M
40.49%1.94M
447.46%4.30M
2440.65%11.69M
--2.81M
--1.38M
--786.00K
--460.00K
----
----
----
Total current liabilities
-29.30%3.84M
-58.56%3.94M
-55.15%5.19M
-58.99%5.35M
-63.71%5.43M
-7.19%9.50M
6.49%11.58M
-78.47%13.05M
-69.99%14.95M
-76.20%10.23M
-69.57%10.87M
--60.63M
--49.83M
--42.99M
--35.73M
----
----
----
Total assets
-36.33%9.59M
-37.55%8.86M
110.74%14.03M
45.41%9.35M
103.43%15.06M
41.55%14.18M
-64.18%6.66M
-36.82%6.43M
-10.34%7.41M
285.79%10.02M
1048.76%18.59M
--10.18M
--8.26M
--2.60M
--1.62M
----
----
----
Total liabilities
-40.04%4.66M
-58.26%5.10M
-58.49%6.83M
-59.99%7.28M
-64.67%7.76M
-33.09%12.21M
-16.39%16.45M
-71.72%18.18M
-59.11%21.98M
-57.97%18.25M
-45.24%19.68M
--64.29M
--53.75M
--43.44M
--35.94M
----
----
----
Total equity
-32.39%4.93M
91.01%3.76M
173.46%7.20M
117.67%2.08M
150.09%7.30M
123.90%1.97M
-795.61%-9.80M
78.28%-11.75M
67.97%-14.57M
79.84%-8.23M
96.81%-1.09M
---54.11M
---45.49M
---40.84M
---34.33M
----
----
----
Net operating income
42.28%-4.12M
6.99%-5.04M
14.31%-4.24M
11.18%-4.88M
-86.14%-7.13M
-4.57%-5.42M
63.41%-4.95M
-6.21%-5.49M
-23.30%-3.83M
-33.80%-5.19M
-216.19%-13.52M
-74.94%-5.17M
-47.53%-3.11M
-41.20%-3.88M
---4.28M
---2.96M
---2.11M
---2.75M
Net investment
28.57%-5.00K
-1480.00%-79.00K
-350.00%-27.00K
---57.00K
-40.00%-7.00K
85.71%-5.00K
90.48%-6.00K
100.00%0.00
96.35%-5.00K
78.26%-35.00K
52.63%-63.00K
-140.59%-243.00K
-38.38%-137.00K
-496.30%-161.00K
---133.00K
---101.00K
---99.00K
---27.00K
Net financing
-36.37%5.16M
-97.41%340.00K
56.80%9.48M
-109.02%-469.00K
169.10%8.11M
543.07%13.11M
-72.06%6.05M
-20.91%5.20M
-20.52%3.01M
-168.49%-2.96M
408.36%21.64M
136.51%6.58M
417.90%3.79M
189.48%4.32M
--4.26M
--2.78M
--732.00K
--1.49M

FAQs

What are the current assets of Calidi Biotherapeutics Inc?

According to Calidi Biotherapeutics Inc's FY2025 earnings report, its current assets were 6.26M, with a year-on-year change of -38.83.

What are the total assets of Calidi Biotherapeutics Inc?

According to Calidi Biotherapeutics Inc's FY2025 earnings report, its total assets of Calidi Biotherapeutics Inc were 8.86M, with a year-on-year change of -37.55.

What are the total liabilities of Calidi Biotherapeutics Inc?

According to Calidi Biotherapeutics Inc's FY2025 earnings report, its total liabilities of Calidi Biotherapeutics Inc were 5.10M, with a year-on-year change of -58.26.

What is the total equity of Calidi Biotherapeutics Inc?

According to Calidi Biotherapeutics Inc's FY2025 earnings report, its total equity of Calidi Biotherapeutics Inc was 3.76M, with a year-on-year change of 91.01.

What is the net operating income of Calidi Biotherapeutics Inc?

According to Calidi Biotherapeutics Inc's FY2025 earnings report, its net operating income of Calidi Biotherapeutics Inc was -20.24M, with a year-on-year change of 7.05.

What is the net investment of Calidi Biotherapeutics Inc?

According to Calidi Biotherapeutics Inc's FY2025 earnings report, its net investment of Calidi Biotherapeutics Inc was -170.00K, with a year-on-year change of -962.50.

What is the net financing of Calidi Biotherapeutics Inc?

According to Calidi Biotherapeutics Inc's FY2025 earnings report, its net financing of Calidi Biotherapeutics Inc was 17.46M, with a year-on-year change of -36.20.

What is the Earnings Per Share (EPS) of Calidi Biotherapeutics Inc?

According to Calidi Biotherapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -5.95, with a year-on-year change of 83.34.

What is the net income of Calidi Biotherapeutics Inc?

According to Calidi Biotherapeutics Inc's FY2025 earnings report, its net income was -25.58M, with a year-on-year change of -7.41.

What is the debt-to-asset ratio of Calidi Biotherapeutics Inc?

According to Calidi Biotherapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 9.96, with a year-on-year change of -64.58.

What is the Return on Assets (ROA) of Calidi Biotherapeutics Inc?

According to Calidi Biotherapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -174.17, with a year-on-year change of 5.11.

What is the operating profit of Calidi Biotherapeutics Inc?

According to Calidi Biotherapeutics Inc's FY2025 earnings report, its operating profit was -20.24M, with a year-on-year change of 7.05.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.